{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:04:29Z","timestamp":1789545869264,"version":"build-2803163510"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,16]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Pulmonary aspergillosis is a pulmonary infectious disease that is clinically difficult to diagnose and treat. When the lower respiratory tract is invaded by Aspergillus, the clinical manifestations and imaging features vary among patients with different immune states. The use of antifungal drugs and glucocorticoids are important, but some patients do not respond satisfactorily to treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>A 59-year-old female had a long history of asthma and poor symptom control, with long-term use of long-acting inhaled glucocorticoids combined with a long-acting \u03b22 receptor agonists (ICS\u2005+\u2005LABA) (salmeterol fluticasone inhalation powder). The ground glass shadow, tree-in-bud sign, and bronchiectasis in the middle lobe of the right lung and the lower lobe of both lungs were first detected by chest CT over 5 years ago. Atelectasis in the middle lobe of the right lung was detected over 3 years ago. Over 2 years ago, the patient was hospitalized and a repeat chest CT showed persistent atelectasis in the middle lobe of the right lung, and more lesions in bilateral lower lungs than before. Aspergillus fumigatus was detected in alveolar lavage fluid and sputum pathogenic culture, which confirmed the diagnosis of pulmonary aspergillosis. After treatment with voriconazole and amphotericin B, the middle lobe of the right lung partially reopened, but the lesions in bilateral lower lungs persisted. After 21 weeks of treatment, the antifungal drugs were stopped because the patient refused to use oral\/intravenous glucocorticoids, and omalizumab was finally chosen for treatment. After 1 month of treatment, the patient\u2019s clinical symptoms began to ease. After 1 year of treatment, imaging reexamination of lung showed that the lesions were completely cleared, accompanied by significant improvement in nutritional status and airway function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>We reported the case of a patient with pulmonary Aspergillus infection who was treated with omalizumab and showed significant improvement in clinical symptoms and imaging abnormalities, which provides a new option for patients with pulmonary Aspergillus infection who show unsatisfactory response with first-line drugs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000033845","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T18:06:28Z","timestamp":1686938788000},"page":"e33845","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Pulmonary aspergillus infection with abnormal imaging successfully treated with omalizumab: A case report"],"prefix":"10.1097","volume":"102","author":[{"given":"Xing","family":"He","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Cheng Du Qing Cheng Mt. Hospital, Chongzhou City, Chengdu, China"},{"name":"Department of Pulmonary and Critical Care Medicine, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Cheng Du Qing Cheng Mt. Hospital, Chongzhou City, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9243-1283","authenticated-orcid":false,"given":"Haiying","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Cheng Du Qing Cheng Mt. Hospital, Chongzhou City, Chengdu, China"},{"name":"Department of Pulmonary and Critical Care Medicine, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Weng","sequence":"additional","affiliation":[{"name":"School of Mathematics, Sichuan University, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious disease\u2019s society of America.","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/myc.12727","article-title":"Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: an illustrative case study.","volume":"61","author":"Hoenigl","year":"2018","journal-title":"Mycoses"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s15010-012-0322-x","article-title":"Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.","volume":"40","author":"Saito","year":"2012","journal-title":"Infection"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000507216","article-title":"Effectiveness and Safety of omalizumab in patients with allergic bronchopulmonary aspergillosis complicated by chronic bacterial infection in the airways.","volume":"181","author":"Tomomatsu","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium.","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1200\/JCO.2012.43.1817","article-title":"EMA\/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.","volume":"31","author":"Alifrangis","year":"2013","journal-title":"J Clin Oncol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/02770907009108360","article-title":"Middle lobe syndrome and intractable asthma.","volume":"8","author":"Caplin","year":"1970","journal-title":"J Asthma Res"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"e00535","DOI":"10.1128\/msphere.00535-20","article-title":"Biotinylated surfome profiling identifies potential biomarkers for diagnosis and therapy of aspergillus fumigatus infection.","volume":"5","author":"Jia","year":"2020","journal-title":"mSphere"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.mycmed.2018.09.006","article-title":"Aspergillus fumigatus conidia stimulate lung epithelial cells (TC-1 JHU-1) to produce IL-12, IFN\u03b3, IL-13 and IL-17 cytokines: modulatory effect of propolis extract.","volume":"28","author":"Khosravi","year":"2018","journal-title":"J Mycol Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/17476348.2019.1666002","article-title":"Role of IL-17 in asthma pathogenesis and its implications for the clinic.","volume":"13","author":"Ramakrishnan","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/resp.14096","article-title":"Anti-IgE therapy inhibits chemotaxis, proliferation and transformation of circulating fibrocytes in patients with severe allergic asthma.","volume":"26","author":"Wang","year":"2021","journal-title":"Respirology"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1111\/all.14833","article-title":"Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab.","volume":"76","author":"Manohar","year":"2021","journal-title":"Allergy"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1378\/chest.12-3073","article-title":"Mechanisms of airway remodeling.","volume":"144","author":"Hirota","year":"2013","journal-title":"Chest"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e56015","DOI":"10.1371\/journal.pone.0056015","article-title":"The role of IgE-receptors in IgE-dependent airway smooth muscle cell remodelling.","volume":"8","author":"Roth","year":"2013","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:09:45Z","timestamp":1746320985000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":15,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033845","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,16]]}}}